FindTrial
Sign In

Changes in gut microbiota of GD patients and the impact of bifidobacteria on GD

Changes in gut microbiota of GD patients and the impact of bifidobacteria on GD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128014
Enrollment
Unknown
Registered
2026-07-13
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyroidism

Interventions

131I radiotherapy treatment group:None

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with Graves' disease (GD)-induced hyperthyroidism; 2. Presence of hypermetabolic symptoms and signs; 3. Elevated free triiodothyronine (FT3) and free thyroxine (FT4) levels with suppressed thyroid-stimulating hormone (TSH),Positive thyrotropin receptor antibody (TRAb); 4. Thyroid ultrasound indicating diffuse thyroid enlargement;

Exclusion criteria

Exclusion criteria: 1.The patient has gastrointestinal disorders.

Design outcomes

Primary

MeasureTime frame
The thyroid hormone levels decreased;—

Secondary

MeasureTime frame
The thyroid hormone levels decreased;—

Countries

China

Contacts

Public ContactShi Kexin

The First Affiliated Hospital of Wenzhou Medical University

15868093221@163.com+86 577 55579052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026